# Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis

> **NCT01416493** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alloksys Life Sciences B.V.** · enrollment: 6 (actual)

## Conditions studied

- Acute Rheumatoid Arthritis

## Interventions

- **DRUG:** s.c. injections of bovine intestinal Alkaline Phosphatase

## Key facts

- **NCT ID:** NCT01416493
- **Lead sponsor:** Alloksys Life Sciences B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2015-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416493, "Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01416493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*